COMMUNIQUÉS West-GlobeNewswire

Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
17/06/2025
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial [...]
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
17/06/2025
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health [...]
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
17/06/2025
The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF and plasma exposures reinforce VTX3232’s potential as a once-daily oral therapy for [...]
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
17/06/2025
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., June 17, 2025 (GLOBE [...]
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
17/06/2025
REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious [...]
Counslr Partners with Hacking HR to Provide 24/7 Mental Health Support for Members
17/06/2025
Supporting Professionals Who Are Shaping the Future of Work NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Hacking HR, the fastest growing global community of HR leaders and practitioners, announced its partnership with [...]
Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide
17/06/2025
Late-breaking poster presentation to be reviewed at the upcoming American Diabetes Association’s 85th Scientific Sessions BOSTON and SHANGHAI, June 17, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage [...]
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
17/06/2025
Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward Commercialization CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. ( [...]
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
17/06/2025
- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - CLS-AX Combines the Flexibility of Anti-VEGF Therapies with the Long-Lasting Benefits of a Tyrosine Kinase Inhibitor - [...]
ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025
17/06/2025
EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
17/06/2025
ORION CORPORATION PRESS RELEASE 17 JUNE 2025 at 9.00 EEST Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs Orion Corporation and [...]
Evosep Joins P4ML to Power World’s Largest Multi-Omic Human Health Study of Two Million Samples
17/06/2025
SAINT-MALO, France, June 17, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMIC-Assist Study— [...]
Llusern Scientific Announces ISO 13485 Certification for its Point-of-Care Diagnostics System for Urinary Tract Infections
17/06/2025
CARDIFF, United Kingdom, June 17, 2025 (GLOBE NEWSWIRE) -- Llusern Scientific, a point-of-care diagnostics company, announces it has been awarded ISO 13485 certification for its Lodestar DX testing system, a rapid [...]
Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering
17/06/2025
New Taipei City, Taiwan, June 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (the “Company”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and [...]
Vivoryon Therapeutics N.V. Q1 2025 Financial Results and Operational Progress
17/06/2025
Vivoryon Therapeutics N.V. Q1 2025 Financial Results and Operational Progress Continued progress in advancing varoglutamstat in kidney disease based on encouraging data and expansion of IP portfolio Varoglutamstat’s pre [...]
Dr. Elad Yossefi and Dr. Tal Yossefi Introduce Tech-Enhanced Dental Services in Norwalk
17/06/2025
Advanced Dental Center Expands Full-Mouth Restoration and Gum Disease Treatment with Modern Tools Norwalk, CT / USA, June 16, 2025 (GLOBE NEWSWIRE) -- Norwalk, CT — Advanced Dental Center in Norwalk, Connecticut, led by [...]
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
17/06/2025
The Company Anticipates that with this Additional Funding, PolyPid’s Runway would be Extended beyond Anticipated U.S. Food and Drug Administration (“FDA”) Approval of D-PLEX₁₀₀ . The Company Recently Announced [...]
TLI Executive Director Featured in Medical Economics: New Article Highlights Innovations In Autism Care Models
16/06/2025
MCLEAN, Va., June 16, 2025 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) proudly announces the publication of a new article by Executive Director Shawn Murphy in Medical Economics , titled [...]
Dyne Therapeutics to Host Investor Conference Call and Webcast to Provide Update on DYNE-101 for Myotonic Dystrophy Type 1, Tomorrow Tuesday, June 17 at 8:00 a.m. ET
16/06/2025
WALTHAM, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming therapeutics for people living [...]

Pages